<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>Insight数据库 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-22T20:44:54+08:00</updated>
  <subtitle>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020 年国内「十大新药」榜单发布！PD-1、ALK、PARP……这些品种在列</title>
    <updated>2021-01-22T17:43:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/J3Qoo0dqwASBkjDyO4XBFg</id>
    <link href="https://mp.weixin.qq.com/s/J3Qoo0dqwASBkjDyO4XBFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刚刚，5 款仿制药通过一致性评价，2 款首家</title>
    <updated>2021-01-22T17:43:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/hayBwE2kfRE-i1bHZvMIbQ</id>
    <link href="https://mp.weixin.qq.com/s/hayBwE2kfRE-i1bHZvMIbQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GSK 艾滋病新药「多替拉韦利匹韦林片」上市申请拟优先审评</title>
    <updated>2021-01-22T17:43:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/9mecFy4rQbyc038o6L2-7g</id>
    <link href="https://mp.weixin.qq.com/s/9mecFy4rQbyc038o6L2-7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>云顶新耀 Trop-2 ADC 启动 III 期临床，乳腺癌三线治疗</title>
    <updated>2021-01-22T17:43:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-22:/s/DbYddBXgTn4njvRiRO70Ng</id>
    <link href="https://mp.weixin.qq.com/s/DbYddBXgTn4njvRiRO70Ng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达 PD-1 新适应症上市申请拟优先审评，晚期肝癌一线治疗</title>
    <updated>2021-01-21T16:39:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/vf5uYGNyuQ6sJlvRietCow</id>
    <link href="https://mp.weixin.qq.com/s/vf5uYGNyuQ6sJlvRietCow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日 5 款仿制药首家过评，3 款为首仿；3 个第四批国采品种又有企业获批</title>
    <updated>2021-01-21T16:39:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/SArtREV2JHLwH811bjS6Cg</id>
    <link href="https://mp.weixin.qq.com/s/SArtREV2JHLwH811bjS6Cg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>礼来「雷莫芦单抗」上市申请获受理，4 大癌种适应症已获 FDA 批准</title>
    <updated>2021-01-21T16:39:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/62pGOtx1CUA3E0ZvMG2g_w</id>
    <link href="https://mp.weixin.qq.com/s/62pGOtx1CUA3E0ZvMG2g_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田制药 ALK 抑制剂上市申请获受理，NCCN 指南推荐一线首选</title>
    <updated>2021-01-21T16:39:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/Hzb4NUzUfZrxbSuvv2J14A</id>
    <link href="https://mp.weixin.qq.com/s/Hzb4NUzUfZrxbSuvv2J14A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>盘点 2020 | 药圈数字化转型元年，丁香园在做什么？</title>
    <updated>2021-01-21T16:39:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/jBY11bITnLUw4BXdFOrYZQ</id>
    <link href="https://mp.weixin.qq.com/s/jBY11bITnLUw4BXdFOrYZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>4 款进口新药拟突破性疗法，2 款来自武田制药</title>
    <updated>2021-01-20T18:54:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/qRja9-qGa5VIApazHuqJow</id>
    <link href="https://mp.weixin.qq.com/s/qRja9-qGa5VIApazHuqJow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日，拜耳心衰新药获 FDA 批准上市，国内已纳入优先审评</title>
    <updated>2021-01-20T18:54:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/uR5ZHUAoXAIxGLdA-T9nQg</id>
    <link href="https://mp.weixin.qq.com/s/uR5ZHUAoXAIxGLdA-T9nQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴 PD-1 联合安罗替尼一线晚期肝癌 III 期临床取得积极结果</title>
    <updated>2021-01-20T18:54:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/xFdF33xY0hy7KBGaAAn6Yg</id>
    <link href="https://mp.weixin.qq.com/s/xFdF33xY0hy7KBGaAAn6Yg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康方生物 PD-1/CTLA-4 双抗最新临床结果发布，联合化疗一线治疗胃癌</title>
    <updated>2021-01-20T18:54:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/QRzoR8NI_WGZtl-atqMUow</id>
    <link href="https://mp.weixin.qq.com/s/QRzoR8NI_WGZtl-atqMUow" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信立泰「特立帕肽注射液」上市申请获受理</title>
    <updated>2021-01-20T18:54:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/0Tyvj7NCAdPF89Vxram9FA</id>
    <link href="https://mp.weixin.qq.com/s/0Tyvj7NCAdPF89Vxram9FA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>这 59 个新药，获批临床了</title>
    <updated>2021-01-19T17:39:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/A4XDim3ydd1iTtJM45bdIg</id>
    <link href="https://mp.weixin.qq.com/s/A4XDim3ydd1iTtJM45bdIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信达「贝伐珠单抗」再次出海，授权 Etana 将达攸同推向印尼市场</title>
    <updated>2021-01-19T17:39:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/VzqkZeOnOuZo9OLO_W0lag</id>
    <link href="https://mp.weixin.qq.com/s/VzqkZeOnOuZo9OLO_W0lag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>先声药业 CDK4/6 抑制剂获批临床，化疗患者骨髓保护</title>
    <updated>2021-01-19T17:39:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/2Cf46BracPsk2PeAbE6FKw</id>
    <link href="https://mp.weixin.qq.com/s/2Cf46BracPsk2PeAbE6FKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>今日，12 款仿制药获批，5 款仿制药通过一致性评价（附第四批国采最新竞争格局）</title>
    <updated>2021-01-18T17:44:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/-_6t2vwoYO38GZC-mZnBuw</id>
    <link href="https://mp.weixin.qq.com/s/-_6t2vwoYO38GZC-mZnBuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>专业解读 | 《药品上市后变更管理办法》哪些要点必须注意？</title>
    <updated>2021-01-18T17:44:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/R3H2M6tn9v3bD9TFNV5m_Q</id>
    <link href="https://mp.weixin.qq.com/s/R3H2M6tn9v3bD9TFNV5m_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首个异体 CAR-T 产品启动临床，来自亘喜生物</title>
    <updated>2021-01-18T17:44:40+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/xZ1_GO4-nASbvAaCVWF_aQ</id>
    <link href="https://mp.weixin.qq.com/s/xZ1_GO4-nASbvAaCVWF_aQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>